Sonal Singh to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Sonal Singh has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Singh S, Go AS, Wenger NK, Zoungas S, Gurwitz JH. Reply to: Statins for Primary Prevention in Older Adults. J Am Geriatr Soc. 2019 04; 67(4):857-858.
Singh S, Zieman S, Go AS, Fortmann SP, Wenger NK, Fleg JL, Radziszewska B, Stone NJ, Zoungas S, Gurwitz JH. Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making. J Am Geriatr Soc. 2018 11; 66(11):2188-2196.
Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 2006; 29(12):1123-32.
Singh S. Drug induced pancreatitis might be a class effect of statin drugs. JOP. 2005 Jul 08; 6(4):380; author reply 380-1.
Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP. 2004 Nov 10; 5(6):502-4.
Singh S, Shrivastava R, Das V. Formulary conversion programs: the need for patient-specific risk assessment. MedGenMed. 2004 Sep 14; 6(3):28.
Kwok CS, Yeong JK, Turner RM, Cavallazzi R, Singh S, Loke YK. Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies. Eur J Clin Pharmacol. 2012 May; 68(5):747-55.
Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, Eyawo O, Guyatt G, Berwanger O, Briel M. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011 Feb; 104(2):109-24.